Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research Article

Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland

Authors: Jean-Pierre Gutzwiller, Jean-Pierre Richterich, Zeno Stanga, Urs E. Nydegger, Lorenz Risch, Martin Risch

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

Osteoporosis is an important morbidity factor for ageing populations in developed countries. However, compared to the amount of information available on diabetes and cardiovascular disease, little is known about the direct impact of osteoporosis on general mortality in older age.

Methods

We obtained data from a prospective population-based cohort of pensioners from the SENIORLAB study who were subjectively healthy. The inclusion criteria were an age of at least 60 years and Swiss residence. We assessed and analysed clinical measures, voluntary reports, and laboratory values.

Results

In total, 1467 subjects were included in the cohort. The mean follow-up time was 3.68 years (95% confidence interval, 3.64–3.71). The ages of the included participants ranged from 60 to 99 years. At follow-up, there were 1401 survivors, and 66 participants had died. According to the multivariate analysis (Cox regression), osteoporosis was the most important risk factor for all-cause mortality (hazard ratio, 4.46; 95% confidence interval, 1.82–10.91), followed by diabetes (hazard ratio, 2.17; 95% confidence interval, 1.04–4.52) and hypertension (hazard ratio, 1.81; 95% confidence interval, 1.09–3.03).

Conclusions

Osteoporosis is a major risk factor for all-cause mortality in a subjectively healthy senior population, followed by type 2 diabetes mellitus and hypertension. Osteoporosis should be more actively diagnosed in healthy pensioners before they develop osteoporosis-associated health incidents.

Trial registration

The present study was registered in the International Standard Randomized Controlled Trial Number registry: ISRCTN53778569.
Literature
1.
go back to reference Panorama. Swiss Federal Office of Statistics. February 2016 FSO do-d-00.01-pan-01. Panorama. Swiss Federal Office of Statistics. February 2016 FSO do-d-00.01-pan-01.
2.
3.
go back to reference Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin JM. Risk factors for 5-year mortality in older adults. The cardiovascular health study. JAMA. 1998;279:585–92.CrossRefPubMed Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin JM. Risk factors for 5-year mortality in older adults. The cardiovascular health study. JAMA. 1998;279:585–92.CrossRefPubMed
4.
go back to reference Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57.CrossRefPubMed Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57.CrossRefPubMed
5.
go back to reference Lippuner K, Grifone S, Schwenkglenks M, Schwab P, Popp AW, Senn C, Perrelet R. Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. Osteoporos Int. 2012;23(3):829–39.CrossRefPubMed Lippuner K, Grifone S, Schwenkglenks M, Schwab P, Popp AW, Senn C, Perrelet R. Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. Osteoporos Int. 2012;23(3):829–39.CrossRefPubMed
6.
go back to reference Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon M, Melton LJ III. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001–5.CrossRefPubMed Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon M, Melton LJ III. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001–5.CrossRefPubMed
7.
go back to reference Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Trémollières F, Roux C. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine. 2012;79:304–13.CrossRefPubMed Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Trémollières F, Roux C. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine. 2012;79:304–13.CrossRefPubMed
8.
go back to reference Mussolino ME, Madans JH, Gillum RF. Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol. 2003;13:692–7.CrossRefPubMed Mussolino ME, Madans JH, Gillum RF. Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol. 2003;13:692–7.CrossRefPubMed
9.
go back to reference Van Der Klift M, Pols HA, Geleijnse JM, Van Der Kuip DA, Hofman A, De Laet CE. Bone mineral density and mortality in elderly men and women: the Rotterdam Study. Bone. 2002;30:643–8.CrossRefPubMed Van Der Klift M, Pols HA, Geleijnse JM, Van Der Kuip DA, Hofman A, De Laet CE. Bone mineral density and mortality in elderly men and women: the Rotterdam Study. Bone. 2002;30:643–8.CrossRefPubMed
10.
go back to reference Suzuki T, Yoshida H. Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int. 2010;21:71–9.CrossRefPubMed Suzuki T, Yoshida H. Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int. 2010;21:71–9.CrossRefPubMed
11.
go back to reference Svedbom A, Ivergard M, Hernlund E, Rizzoli R, Kanis JA. Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos. 2014;9:187.CrossRefPubMed Svedbom A, Ivergard M, Hernlund E, Rizzoli R, Kanis JA. Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos. 2014;9:187.CrossRefPubMed
12.
go back to reference Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, EV MC, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.CrossRefPubMedPubMedCentral Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, EV MC, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.CrossRefPubMedPubMedCentral
14.
go back to reference Abrahamsen B, Osmond C, Cooper C. Life expectancy in patients treated for osteoporosis: Obervational cohort study using National Danish Prescription Data. J Bone Miner Res. 2015;30(9):1553–9.CrossRefPubMed Abrahamsen B, Osmond C, Cooper C. Life expectancy in patients treated for osteoporosis: Obervational cohort study using National Danish Prescription Data. J Bone Miner Res. 2015;30(9):1553–9.CrossRefPubMed
15.
go back to reference Buckens CF, van der Graaf Y, Verkooijen HM, Mali WP, Isgum I, Mol CP, Verhaar HJ, Vliegenthart R, Oudkerk M, van Aalst CM, de Koning HJ, de Jong PA. Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality. Eur Radiol. 2015;25:132–9.CrossRefPubMed Buckens CF, van der Graaf Y, Verkooijen HM, Mali WP, Isgum I, Mol CP, Verhaar HJ, Vliegenthart R, Oudkerk M, van Aalst CM, de Koning HJ, de Jong PA. Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality. Eur Radiol. 2015;25:132–9.CrossRefPubMed
17.
go back to reference Klop C, Welsing PMJ, Cooper C, Harvey NC, Elders PJM, Bijlsmas JWJ, Leufkens HGM, de Vries F. Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone. 2014;66:171–7.CrossRefPubMed Klop C, Welsing PMJ, Cooper C, Harvey NC, Elders PJM, Bijlsmas JWJ, Leufkens HGM, de Vries F. Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone. 2014;66:171–7.CrossRefPubMed
18.
go back to reference Brozek W, Reichardt B, Kimberger O, Zwerina J, Dimai HP, Kritsch D, Klaushofer K, Zwettler E. Mortality after hip fracture in Austria 2008-2011. Calcif Tissue Int. 2014;95:257–66.CrossRefPubMed Brozek W, Reichardt B, Kimberger O, Zwerina J, Dimai HP, Kritsch D, Klaushofer K, Zwettler E. Mortality after hip fracture in Austria 2008-2011. Calcif Tissue Int. 2014;95:257–66.CrossRefPubMed
19.
go back to reference Thomas-John M, Codd MB, Manne S, Watts NB, Mongey AB. Risk factors for the development of osteoporosis and osteoporotic fractures among older men. J Rheumatol. 2009;36:1947–52.CrossRefPubMed Thomas-John M, Codd MB, Manne S, Watts NB, Mongey AB. Risk factors for the development of osteoporosis and osteoporotic fractures among older men. J Rheumatol. 2009;36:1947–52.CrossRefPubMed
20.
go back to reference Center JR, Bliuc D, Nguyen ND, Nguyen TV, Eisman JA. Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab. 2011;96(4):1006–14.CrossRefPubMed Center JR, Bliuc D, Nguyen ND, Nguyen TV, Eisman JA. Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab. 2011;96(4):1006–14.CrossRefPubMed
21.
go back to reference Warnes AM. Cause-Specific Late-Age Mortality Rates as Indicators for Public Health Priorities. In: Espace, populations, sociéteés, 2000–3. Le vieillissement dans le monde. pp.437–450. Warnes AM. Cause-Specific Late-Age Mortality Rates as Indicators for Public Health Priorities. In: Espace, populations, sociéteés, 2000–3. Le vieillissement dans le monde. pp.437–450.
22.
go back to reference Wild S, Sicree R, Roglic G, King H, Green A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed Wild S, Sicree R, Roglic G, King H, Green A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed
23.
go back to reference Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, Incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol. 2003;18:793–800.CrossRefPubMed Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, Incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol. 2003;18:793–800.CrossRefPubMed
24.
go back to reference McBean M, Gilbertson D, Li S, Collins A. Differences in diabetes prevalence, incidence and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care. 2004;27:2317–24.CrossRefPubMed McBean M, Gilbertson D, Li S, Collins A. Differences in diabetes prevalence, incidence and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care. 2004;27:2317–24.CrossRefPubMed
25.
go back to reference Wilson P, Anderson K, Kannel W. Epidemiology of diabetes mellitus in the elderly. The Framingham study Am J Med. 1986;80(Suppl. 5a):3–9.PubMed Wilson P, Anderson K, Kannel W. Epidemiology of diabetes mellitus in the elderly. The Framingham study Am J Med. 1986;80(Suppl. 5a):3–9.PubMed
26.
go back to reference Lee P, Alexander KP, Hammill BG, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286:708–13.CrossRefPubMed Lee P, Alexander KP, Hammill BG, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286:708–13.CrossRefPubMed
27.
go back to reference Croxson SCM, Price DE, Burden M, Jagger C, Burden AC. The mortality of elderly people with diabetes. Diabet Med. 1994;11:250–2.CrossRefPubMed Croxson SCM, Price DE, Burden M, Jagger C, Burden AC. The mortality of elderly people with diabetes. Diabet Med. 1994;11:250–2.CrossRefPubMed
28.
go back to reference Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ. Diabetes mellitus subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol. 2000;20:823–9.CrossRefPubMed Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ. Diabetes mellitus subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol. 2000;20:823–9.CrossRefPubMed
29.
go back to reference Barnett KN, McMurdo MET, Ogston SA, Morris AD, Evans JMM. Mortality in people diagnosed with type 2 diabetes at an older age: a systemic review. Age Ageing. 2006;35:463–8.CrossRefPubMed Barnett KN, McMurdo MET, Ogston SA, Morris AD, Evans JMM. Mortality in people diagnosed with type 2 diabetes at an older age: a systemic review. Age Ageing. 2006;35:463–8.CrossRefPubMed
31.
go back to reference Weidung B, Boström G, Toots A, Nordström P, Carlberg B, Gustafson Y, Littbrand H. Blood pressure, gait speed, and mortality in very old individuals: a population-based cohort study. J Am Med Dir Assoc. 2015;16(3):208–14.CrossRefPubMed Weidung B, Boström G, Toots A, Nordström P, Carlberg B, Gustafson Y, Littbrand H. Blood pressure, gait speed, and mortality in very old individuals: a population-based cohort study. J Am Med Dir Assoc. 2015;16(3):208–14.CrossRefPubMed
32.
go back to reference Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM, SPRINT research group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–82. https://doi.org/10.1001/jama.2016.7050. CrossRefPubMedPubMedCentral Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM, SPRINT research group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–82. https://​doi.​org/​10.​1001/​jama.​2016.​7050.​ CrossRefPubMedPubMedCentral
33.
go back to reference Huynh QL, Reid CM, Chowdhury EK, Huq MM, Billah B, Wing LM, Tonkin AM, Simons LA. Nelson MR; second Australian National Blood Pressure Management Committee. Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged population. Am J Hypertens. 2015;28(5):649–56.CrossRefPubMed Huynh QL, Reid CM, Chowdhury EK, Huq MM, Billah B, Wing LM, Tonkin AM, Simons LA. Nelson MR; second Australian National Blood Pressure Management Committee. Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged population. Am J Hypertens. 2015;28(5):649–56.CrossRefPubMed
34.
go back to reference Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM. Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat. 2014;146(2):401–9.CrossRefPubMedPubMedCentral Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM. Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat. 2014;146(2):401–9.CrossRefPubMedPubMedCentral
35.
go back to reference D E, Paccaud F, Vollenweider P, Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health. 2011;11:114.CrossRef D E, Paccaud F, Vollenweider P, Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health. 2011;11:114.CrossRef
Metadata
Title
Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland
Authors
Jean-Pierre Gutzwiller
Jean-Pierre Richterich
Zeno Stanga
Urs E. Nydegger
Lorenz Risch
Martin Risch
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0809-0

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue